Don E. Ray
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Don E. Ray
Don E. Ray is recorded as CFO at Regenerex Pharma, Inc. (RGPX). Regenerex Pharma, Inc. reported in an 8-K filed May 6, 2026 that Don E. Ray was appointed Interim Chief Financial Officer, effective April 1, 2026. Regenerex Pharma, Inc. reported in an 8-K filed April 2, 2026 that Don E. Ray was appointed Interim Chief Financial Officer, effective April 1, 2026.
“on April 1, 2026, the Board appointed Don E. Ray to serve as Interim Chief Financial Officer of the Company.”
“Effective April 1, 2026, the Board appointed Don E. Ray to serve as Interim Chief Financial Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Regenerex Pharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Gregory P. Pilant CEO, Chairman, Board Member
- Brent Wilson CFO
- Deborah L. Pilant CFO
- Kenneth W. Perry CFO
- Lee Ori COO, Board Member
- Troy Thuet COO
- Dr Lee Ori Board Member
- J. Kenneth Hazen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.